Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 631

1.

Prognostic assessment in COPD without lung function: the B-AE-D indices.

Boeck L, Soriano JB, Brusse-Keizer M, Blasi F, Kostikas K, Boersma W, Milenkovic B, Louis R, Lacoma A, Djamin R, Aerts J, Torres A, Rohde G, Welte T, Martinez-Camblor P, Rakic J, Scherr A, Koller M, van der Palen J, Marin JM, Alfageme I, Almagro P, Casanova C, Esteban C, Soler-Cataluña JJ, de Torres JP, Miravitlles M, Celli BR, Tamm M, Stolz D.

Eur Respir J. 2016 Apr 21. pii: ERJ-01485-2015. doi: 10.1183/13993003.01485-2015. [Epub ahead of print]

PMID:
27103389
2.

Disease progression in recurrent glioblastoma patients treated with the VEGFR inhibitor axitinib is associated with increased regulatory T cell numbers and T cell exhaustion.

Du Four S, Maenhout SK, Benteyn D, De Keersmaecker B, Duerinck J, Thielemans K, Neyns B, Aerts JL.

Cancer Immunol Immunother. 2016 Apr 20. [Epub ahead of print]

PMID:
27098427
3.

Linking Smokers' Susceptibility to Tuberculosis with Lysosomal Storage Disorders.

Meijer AH, Aerts JM.

Dev Cell. 2016 Apr 18;37(2):112-3. doi: 10.1016/j.devcel.2016.04.004.

PMID:
27093080
4.

Investigation of original multivalent iminosugars as pharmacological chaperones for the treatment of Gaucher disease.

Laigre E, Hazelard D, Casas J, Serra-Vinardell J, Michelakakis H, Mavridou I, Aerts JF, Delgado A, Compain P.

Carbohydr Res. 2016 Mar 16. pii: S0008-6215(16)30047-7. doi: 10.1016/j.carres.2016.03.007. [Epub ahead of print]

PMID:
27063390
5.

Pemetrexed plus carboplatin versus pemetrexed in pretreated patients with advanced non-squamous non-small cell lung cancer: treating the right patients based on individualized treatment effect prediction.

van Kruijsdijk RC, Visseren FL, Boni L, Groen HJ, Dingemans AM, Aerts JG, van der Graaf Y, Ardizzoni A, Smit EF.

Ann Oncol. 2016 Apr 6. pii: mdw154. [Epub ahead of print]

PMID:
27052652
6.

Heart rate time series characteristics for early detection of infections in critically ill patients.

Tambuyzer T, Guiza F, Boonen E, Meersseman P, Vervenne H, Hansen TK, Bjerre M, Van den Berghe G, Berckmans D, Aerts JM, Meyfroidt G.

J Clin Monit Comput. 2016 Apr 2. [Epub ahead of print]

PMID:
27039298
7.

Biochemical response to substrate reduction therapy versus enzyme replacement therapy in Gaucher disease type 1 patients.

Smid BE, Ferraz MJ, Verhoek M, Mirzaian M, Wisse P, Overkleeft HS, Hollak CE, Aerts JM.

Orphanet J Rare Dis. 2016 Mar 24;11:28. doi: 10.1186/s13023-016-0413-3.

8.

Dose and Volume of the Irradiated Main Bronchi and Related Side Effects in the Treatment of Central Lung Tumors With Stereotactic Radiotherapy.

Duijm M, Schillemans W, Aerts JG, Heijmen B, Nuyttens JJ.

Semin Radiat Oncol. 2016 Apr;26(2):140-8. doi: 10.1016/j.semradonc.2015.11.002. Epub 2015 Nov 21. Review.

PMID:
27000511
9.

Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.

Baumeler L, Papakonstantinou E, Milenkovic B, Lacoma A, Louis R, Aerts JG, Welte T, Kostikas K, Blasi F, Boersma W, Torres A, Rohde GG, Boeck L, Rakic J, Scherr A, Tamm M, Stolz D.

Respirology. 2016 Mar 11. doi: 10.1111/resp.12758. [Epub ahead of print]

PMID:
26970108
10.

Current applications and future directions for the CDISC Operational Data Model standard: A methodological review.

Hume S, Aerts J, Sarnikar S, Huser V.

J Biomed Inform. 2016 Apr;60:352-62. doi: 10.1016/j.jbi.2016.02.016. Epub 2016 Mar 2. Review.

PMID:
26944737
11.

Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours.

Bialkowski L, van Weijnen A, Van der Jeught K, Renmans D, Daszkiewicz L, Heirman C, Stangé G, Breckpot K, Aerts JL, Thielemans K.

Sci Rep. 2016 Mar 2;6:22509. doi: 10.1038/srep22509.

12.

Maxillary changes with bone-borne surgically assisted rapid palatal expansion: A prospective study.

Asscherickx K, Govaerts E, Aerts J, Vande Vannet B.

Am J Orthod Dentofacial Orthop. 2016 Mar;149(3):374-83. doi: 10.1016/j.ajodo.2015.08.018.

PMID:
26926025
13.

Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab.

Walraven I, van den Heuvel M, van Diessen J, Schaake E, Uyterlinde W, Aerts J, Koppe F, Codrington H, Kunst P, Dieleman E, van de Vaart P, Verheij M, Belderbos J.

Radiother Oncol. 2016 Mar;118(3):442-6. doi: 10.1016/j.radonc.2016.02.011. Epub 2016 Feb 15.

PMID:
26900091
14.

Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases.

Ferraz MJ, Marques AR, Appelman MD, Verhoek M, Strijland A, Mirzaian M, Scheij S, Ouairy CM, Lahav D, Wisse P, Overkleeft HS, Boot RG, Aerts JM.

FEBS Lett. 2016 Mar;590(6):716-25. doi: 10.1002/1873-3468.12104. Epub 2016 Mar 3.

PMID:
26898341
15.

Influence of the Acidic Beverage Cola on the Absorption of Erlotinib in Patients With Non-Small-Cell Lung Cancer.

van Leeuwen RW, Peric R, Hussaarts KG, Kienhuis E, IJzerman NS, de Bruijn P, van der Leest C, Codrington H, Kloover JS, van der Holt B, Aerts JG, van Gelder T, Mathijssen RH.

J Clin Oncol. 2016 Apr 20;34(12):1309-14. doi: 10.1200/JCO.2015.65.2560. Epub 2016 Feb 8.

PMID:
26858332
16.

PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Senan S, Brade A, Wang LH, Vansteenkiste J, Dakhil S, Biesma B, Martinez Aguillo M, Aerts J, Govindan R, Rubio-Viqueira B, Lewanski C, Gandara D, Choy H, Mok T, Hossain A, Iscoe N, Treat J, Koustenis A, San Antonio B, Chouaki N, Vokes E.

J Clin Oncol. 2016 Mar 20;34(9):953-62. doi: 10.1200/JCO.2015.64.8824. Epub 2016 Jan 25.

PMID:
26811519
17.

Non-small cell lung cancer patients with brain metastases treated with first-line platinum-doublet chemotherapy: Analysis from the European FRAME study.

Moro-Sibilot D, Smit E, de Castro Carpeño J, Lesniewski-Kmak K, Aerts JG, Villatoro R, Kraaij K, Nacerddine K, Dyachkova Y, Smith KT, Girvan A, Visseren-Grul C, Schnabel PA.

Lung Cancer. 2015 Dec;90(3):427-32. doi: 10.1016/j.lungcan.2015.11.011. Epub 2015 Nov 10.

PMID:
26791802
18.

Development and Validation of a Small Single-domain Antibody That Effectively Inhibits Matrix Metalloproteinase 8.

Demeestere D, Dejonckheere E, Steeland S, Hulpiau P, Haustraete J, Devoogdt N, Wichert R, Becker-Pauly C, Van Wonterghem E, Dewaele S, Van Imschoot G, Aerts J, Arckens L, Saeys Y, Libert C, Vandenbroucke RE.

Mol Ther. 2016 Jan 18. doi: 10.1038/mt.2016.2. [Epub ahead of print]

PMID:
26775809
19.

Cisplatin and carboplatin-based chemotherapy in the first-line treatment of non-small cell lung cancer: Analysis from the European FRAME study.

Smit E, Moro-Sibilot D, Carpeño Jde C, Lesniewski-Kmak K, Aerts J, Villatoro R, Kraaij K, Nacerddine K, Dyachkova Y, Smith KT, Girvan A, Visseren-Grul C, Schnabel PA.

Lung Cancer. 2016 Feb;92:35-40. doi: 10.1016/j.lungcan.2015.11.022. Epub 2015 Dec 3.

PMID:
26775594
20.

Gpnmb Is a Potential Marker for the Visceral Pathology in Niemann-Pick Type C Disease.

Marques AR, Gabriel TL, Aten J, van Roomen CP, Ottenhoff R, Claessen N, Alfonso P, Irún P, Giraldo P, Aerts JM, van Eijk M.

PLoS One. 2016 Jan 15;11(1):e0147208. doi: 10.1371/journal.pone.0147208. eCollection 2016.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk